HOME
BUSINESS
MARKETS
BIOTECH
LIFESTYLE
TRENDING
Search
Financial Trends
HOME
BUSINESS
MARKETS
BIOTECH
LIFESTYLE
TRENDING
Tag: NASDAQ:MACK
Health
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) Reports Management Change
Aaron Lyons
-
Health
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) Informs On Upcoming Milestones
Brandon Manns
-
Health
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) CEO Says – 1Q 2017 Was Transformative...
Brandon Manns
-
Health
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) To Release 1Q2017 Financials On May 10,...
Brandon Manns
-
Health
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) Commences Phase 1 Trial Of MM-310 In...
Brandon Manns
-
Health
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) Completes Sale of ONIVYDE®
Aaron Lyons
-
Business
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) Announces New Head of Research
Brandon Manns
-
Health
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) Announces The $140M Special Dividend In Line...
Neha Rathod
-
Health
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) To Sell Off Oncology Assets To Ipsen...
Brandon Manns
-
BIOTECH
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) Updates On Phase II HERMIONE Study Of...
Brandon Manns
-
1
2
Page 1 of 2